image
Oncternal Therapeutics, Inc. ONCT
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 1.14
2.7 %
$ 3.37 M
Market Cap
-0.1
P/E
INCOME STATEMENT
785 K REVENUE
-47.32%
Growth Rates
1Year -47.32%
3Years -38.50%
5Years -20.81%
7Years 12.72%
10Years 0.00%
-41.7 M OPERATING INCOME
7.19%
Growth Rates
1Year 7.19%
3Years -33.48%
5Years -1.32%
7Years -7.03%
10Years 0.44%
-39.5 M NET INCOME
10.62%
Growth Rates
1Year 10.62%
3Years -31.85%
5Years -0.55%
7Years -12.12%
10Years 0.64%
EFFICIENCY
Earnings Waterfall Oncternal Therapeutics, Inc.
image
Revenue 785 K
Cost Of Revenue 29.8 M
Gross Profit -29 M
Operating Expenses 12.7 M
Operating Income -41.7 M
Other Expenses -2.24 M
Net Income -39.5 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999
REVENUE
Revenue 0.8 1.5 4.3 3.4 2.4 2.5 1.7 (2.5) 0 0 0 0 14.7 60.6 14.7 13.5 7.1 7.5 3.8 1.9 0 0 0 0 0
GROSS PROFIT
Cost Of Revenue 29.8 0.2 0.2 12.0 10.2 46 K 47 K 2.5 43 K 0 0 0 1.1 0.8 1.3 0.6 0.6 0.8 1.6 0 0 0 0 0 0
Gross Profit (29.0) 1.3 4.1 (8.6) (7.7) 2.5 1.6 (5.0) 43 K 0 0 0 13.7 59.8 13.4 12.9 6.5 6.7 2.2 1.9 0 0 0 0 0
OPERATING INCOME
Operating Expenses 12.7 44.9 31.4 17.5 15.0 39.1 30.7 25.9 21.8 30.3 43.6 49.7 47.4 45.9 60.1 67.4 52.0 45.2 40.8 25.2 14.3 12.0 8.1 4.0 0.8
Selling, General and Administrative Expenses 12.7 13.5 11.6 8.4 7.3 9.4 9.2 8.7 8.2 9.5 11.3 10.8 15.4 17.4 27.7 23.1 13.5 11.4 9.8 7.2 3.5 2.4 2.2 1.2 0.3
Research and Development Expenses 29.8 33.0 24.1 12.5 10.2 29.7 21.5 17.2 13.6 20.9 32.3 38.9 31.9 28.5 32.3 44.3 38.5 33.9 30.9 17.9 10.5 9.3 5.9 2.7 0.5
Operating Income (41.7) (44.9) (31.4) (17.5) (33.1) (39.1) (30.7) (25.9) (21.8) (30.3) (43.6) (49.7) (33.7) 13.9 (46.7) (54.5) (45.5) (38.5) (38.6) (23.3) (14.3) (12.0) (8.1) (4.0) (0.8)
PRE-TAX INCOME
Interest Income Expense 0 (0.7) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income 2.2 0.8 33 K 0.3 (1.1) 1.0 0.2 8.2 3.1 (9.1) 1.5 19 K 0.4 1.4 0.2 2.7 5.1 3.0 1.7 17.6 (81.1) 0 0 0 0
Pre-Tax Income (39.5) (44.2) (31.3) (17.2) (34.2) (38.4) (30.4) (17.7) (18.7) (39.4) (42.1) (49.8) (33.3) 15.3 (46.5) (51.8) (40.4) (35.5) (36.8) (5.7) (95.5) 0 0 0 0
NET INCOME
Tax Provision 0 (0.8) 33 K 16 K (18.3) 0.6 47 K (8.2) (3.1) 8.7 (0.4) (8.8) (1.4) (2.9) (0.2) (1.6) 4.9 (72.0) 0.3 17.2 (0.1) (0.2) 8.1 (0.1) 69 K
Net Income (39.5) (43.4) (31.3) (17.2) (15.9) (38.4) (30.4) (17.7) (18.7) (39.4) (42.1) (27.1) (33.3) 15.3 (46.3) (51.8) (40.4) (35.5) (36.8) (22.3) (14.2) (11.9) (8.1) (3.8) (0.8)
EPS 13.4 16.5 12.7 16.9 30.8 11.5 12.2 8.52 9.33 33.7 46.8 30.2 40.6 27.3 88.9 99.8 80.9 79.8 99.2 68 128 107 72.8 34.5 6.79